Association of Polyphenol Biomarkers with Cardiovascular Disease and Mortality Risk: A Systematic Review and Meta-Analysis of Observational Studies
暂无分享,去创建一个
[1] U. Nöthlings,et al. Association of isoflavone biomarkers with risk of chronic disease and mortality: a systematic review and meta-analysis of observational studies , 2017, Nutrition reviews.
[2] Guido Schwarzer,et al. General Package for Meta-Analysis , 2015 .
[3] J. Dwyer,et al. Dietary flavonoid intakes and CVD incidence in the Framingham Offspring Cohort , 2015, British Journal of Nutrition.
[4] R. Gambino,et al. Dietary flavonoid intake and cardiovascular risk: a population-based cohort study , 2015, Journal of Translational Medicine.
[5] Josette F. Jones,et al. Urinary phytoestrogens and cancer, cardiovascular, and all-cause mortality in the continuous National Health and Nutrition Examination Survey , 2015, European Journal of Nutrition.
[6] S. Bandinelli,et al. Resveratrol levels and all-cause mortality in older community-dwelling adults. , 2014, JAMA internal medicine.
[7] E. Rimm,et al. Inverse association between habitual polyphenol intake and incidence of cardiovascular events in the PREDIMED study. , 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[8] E. Rimm,et al. Polyphenol intake and mortality risk: a re-analysis of the PREDIMED trial , 2014, BMC Medicine.
[9] S. Bandinelli,et al. High concentrations of a urinary biomarker of polyphenol intake are associated with decreased mortality in older adults. , 2013, The Journal of nutrition.
[10] Xia Wang,et al. Flavonoid intake and risk of CVD: a systematic review and meta-analysis of prospective cohort studies , 2013, British Journal of Nutrition.
[11] C. Dethlefsen,et al. Urinary flavonoid excretion and risk of acute coronary syndrome in a nested case-control study. , 2013, The American journal of clinical nutrition.
[12] J. M. Landete,et al. Updated Knowledge about Polyphenols: Functions, Bioavailability, Metabolism, and Health , 2012, Critical reviews in food science and nutrition.
[13] S. Bandinelli,et al. Comparison of 24-h volume and creatinine-corrected total urinary polyphenol as a biomarker of total dietary polyphenols in the Invecchiare InCHIANTI study. , 2011, Analytica chimica acta.
[14] David S. Wishart,et al. Phenol-Explorer: an online comprehensive database on polyphenol contents in foods , 2010, Database J. Biol. Databases Curation.
[15] M. Clifford,et al. Dietary phenolics: chemistry, bioavailability and effects on health. , 2009, Natural product reports.
[16] J. Boer,et al. Plasma enterolignans are not associated with nonfatal myocardial infarction risk. , 2009, Atherosclerosis.
[17] S. Rohrmann,et al. Biomarkers of dietary intake of flavonoids and phenolic acids for studying diet–cancer relationship in humans , 2008, European journal of nutrition.
[18] A. Minihane,et al. Biomarkers of the intake of dietary polyphenols: strengths, limitations and application in nutrition research , 2007, British Journal of Nutrition.
[19] L. Arab,et al. Flavonoids and heart health: proceedings of the ILSI North America Flavonoids Workshop, May 31-June 1, 2005, Washington, DC. , 2007, The Journal of nutrition.
[20] E. Feskens,et al. Intakes of 4 dietary lignans and cause-specific and all-cause mortality in the Zutphen Elderly Study. , 2006, The American journal of clinical nutrition.
[21] J. Virtamo,et al. Serum enterolactone concentration and the risk of coronary heart disease in a case-cohort study of Finnish male smokers. , 2006, American journal of epidemiology.
[22] E. Rimm,et al. Prospective Study on Usual Dietary Phytoestrogen Intake and Cardiovascular Disease Risk in Western Women , 2005, Circulation.
[23] Liliana Jiménez,et al. Polyphenols: food sources and bioavailability. , 2004, The American journal of clinical nutrition.
[24] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[25] J. Salonen,et al. Risk of cardiovascular disease-related and all-cause death according to serum concentrations of enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study. , 2003, Archives of internal medicine.
[26] J. Freudenheim,et al. Biomarkers of nutritional exposure and nutritional status: an overview. , 2003, The Journal of nutrition.
[27] J. Virtamo,et al. Use of oral antimicrobials decreases serum enterolactone concentration. , 2002, American journal of epidemiology.
[28] T. Lakka,et al. Risk of acute coronary events according to serum concentrations of enterolactone: a prospective population-based case-control study , 1999, The Lancet.
[29] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[30] N. Laird,et al. Meta-analysis in clinical trials. , 1986, Controlled clinical trials.
[31] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[32] D. Haytowitz,et al. USDA develops a database for flavonoids to assess dietary intakes , 2013 .
[33] Peter Dalgaard,et al. R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .
[34] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[35] Gary Williamson,et al. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. , 2005, The American journal of clinical nutrition.
[36] S. P. Akpabio. World Health Organisation , 1983, British Dental Journal.